Related Experiment Video

Updated: Jul 19, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Liver steatosis in children with chronic hepatitis C

Maria Guido1, Flavia Bortolotti, Paloma Jara

  • 1Department of Oncological and Surgical Sciences - Pathology Section, University of Padova, Azienda Ospedaliera, Padova, Italy.

The American Journal of Gastroenterology
|November 9, 2006
PubMed

Insights

Steatosis, or fatty liver, is present in 27% of children with chronic hepatitis C. This condition correlates with Body Mass Index (BMI) and triglyceride levels, suggesting a metabolic origin in pediatric cases.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Virology

Background:

  • Steatosis is a common comorbidity in adults with chronic hepatitis C, contributing to fibrosis progression.
  • Limited data exists on the prevalence and characteristics of steatosis in pediatric chronic hepatitis C.
  • Understanding steatosis in children is crucial for managing liver disease progression.

Purpose of the Study:

  • To determine the prevalence and severity of steatosis in children with chronic hepatitis C.
  • To evaluate the correlation between steatosis and clinical parameters, including BMI and serum lipids.
  • To investigate the potential origins of steatosis in this pediatric cohort.

Main Methods:

  • Analysis of liver biopsies from 66 Italian and Spanish children with chronic hepatitis C (predominantly genotype 1).
  • Assessment of steatosis grade and stage using the Ishak system, with specific scoring for severity.
  • Calculation of Body Mass Index-for-age percentile (BMI%) and measurement of serum cholesterol and triglyceride levels.

Main Results:

  • Steatosis was identified in 27% of pediatric patients, with a higher prevalence in Italian compared to Spanish children.
  • A significant correlation was found between BMI% and both the presence and severity of steatosis.
  • Serum triglyceride levels also showed a significant correlation with the presence of steatosis.

Conclusions:

  • Steatosis in children with chronic hepatitis C, particularly genotype 1, is associated with BMI and triglyceride levels.
  • The findings suggest a metabolic rather than purely viral etiology for steatosis in this population.
  • These results highlight the need for considering metabolic factors in the management of pediatric chronic hepatitis C.
Abstract

More Related Videos

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...